Hamideh Pourzand
Primary Care · Los Angeles, CANPI 1700968955
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $92,787 of the $102,706 with a category attached, or 90.3%. Organon accounts for 95.3% of it on its own, with 21 other manufacturers making up the rest. 2025 is the largest year on record at $41,593, more than ten times the $1,196 reported in 2021. Among primary care clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 307 payments — averaging $334.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Organon$98K
- Eisai Inc.$594
- Daiichi Sankyo Inc.$556
- AstraZeneca$493
- Astellas Pharma US Inc$383
- E.r. Squibb & Sons, L.L.C.$364
- plus $2K from 16 others
What the payments were for
- Speaking & faculty fees$92,78790%
- Food & beverage$9,91910%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Organon | 265 | $97,894 |
| Eisai Inc. | 5 | $594 |
| Daiichi Sankyo Inc. | 4 | $556 |
| AstraZeneca | 4 | $493 |
| Astellas Pharma US Inc | 3 | $383 |
| E.r. Squibb & Sons, L.L.C. | 3 | $364 |
| Syndax Pharmaceuticals, Inc. | 2 | $282 |
| Exelixis Inc. | 2 | $265 |
| Seagen Inc. | 2 | $263 |
| Beone Medicines USA, Inc. | 2 | $248 |
| Pfizer | 2 | $204 |
| Lilly USA, LLC | 2 | $143 |
| Coherus Oncology, Inc. | 1 | $125 |
| Kyowa Kirin, Inc. | 1 | $125 |
| Pharmaessentia USA Corporation | 1 | $125 |
| Pharmacosmos Therapeutics Inc. | 1 | $124 |
| Sanofi | 1 | $122 |
| AbbVie | 1 | $120 |
| Regeneron Healthcare Solutions, Inc. | 1 | $113 |
| Novo Nordisk | 2 | $110 |
| Mayne Pharma Commercial LLC | 1 | $28 |
| Exact Sciences | 1 | $25 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$102,706 in reported general payments places this provider in the 95th percentile of 706 primary care providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levothyroxine Sodium | 19 | $416 |
| Atorvastatin Calcium | 25 | $232 |
| Losartan Potassium | 20 | $126 |
| Carvedilol | 11 | $59 |
| Lisinopril | 11 | $42 |
| Azithromycin | 12 | $26 |
Paid to pharmacies, not to this prescriber.
Other primary care in Los Angeles
- Chanyoung KimLos Angeles$5K
- Lisa HsiehLos Angeles$4K
- Leslie FletcherTorrance$1.8M
- Veronica RamirezSacramento$83K
- Tyson FieldstedBakersfield$65K
- Kathryn CooperSan Diego$31K
- Shalaine Corbillala Mesa$22K
- Paula StoddardHanford$22K
- Ashley LoweSan Diego$19K
- Vanessa LeeLong Beach$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.